Tag: JainMatrix Investments

  • IndiGo IPO – Flying High, Wide and Handsome

    Date Oct 27th 2015 IPO Period: 27-29th Oct 2015  Price range: Rs. 700-765 Industry – Airlines. Large Cap – 27,600 crores mkt cap Advice: Good offering with medium risks. BUY with a minimum 1 year horizon Overview: IndiGo is the market leader in Indian aviation with a low cost carrier model. The 97 aircraft cover 647 flights daily to…

  • Café Coffee Day IPO – Very Hot Coffee

    Date 10th Oct 2015 Mid Cap – Rs 4,979 cr Mkt Cap Industry – Coffee QSR, conglomerate Price range: Rs. 316-328 and Period:  14-16th Oct 2015 Advice: Average offering with medium to high risks.  Summary Overview: Coffee Day Enterprises is a conglomerate into coffee, logistics, hospitality, financial services and technology parks. The “Café Coffee Day”…

  • CPSE ETF – Unlocking Value, Slowly

    The CPSE ETF NFO was launched in March 2014, and JainMatrix Investments had evaluated this offer and rated it a BUY. See this report – LINK. See post NFO note – LINK. We now review this ETF for its performance so far and evaluate it as an investment today. Summary The ten CPSE ETF firms…

  • Bajaj Finance – August 2015

    JainMatrix Investments has just published a report on Bajaj Finance. We’ve been tracking this stock since many years. See some of our older reports – 23-Jan-2014 – BAJAJ FINANCE – A FIRM YOU CAN BANK ON 31st Jan 2012 – BAJAJ FINANCE, AUTO-MATIC GROWTH This share has provided 11X returns to shareholders over 5 years, to become one of…

  • Syngene Post IPO report

    Post IPO report dated 17th Aug 2015 Dear Investor, Here is a short post listing report on the Syngene International IPO. The IPO that was open from 27-29th July received excellent response with a 32.05 times over-subscription. While Retail was only 4.8 times oversubscribed, the QIB portion was over 51.5 times and non institutional investors (NII) category…

  • Announcing our launch on Investing.com

    Dear Readers, We are happy to announce our launch on the website, Investing.com. See the links Investing.com India Home Page – http://in.investing.com/ And the Syngene IPO report: http://in.investing.com/analysis/syngene-ipo:-good-pharma-r-d-spinoff-from-biocon-2349 I believe its a very popular website. In their own words, “Investing.com is a global financial portal and internet brand composed of 23 editions in 19 languages …. Founded…

  • Syngene IPO: Good Pharma R&D spinoff from Biocon

    Date – 27th July 2015 Issue Price range: Rs. 240-250 and Issue Period: 27-29th July 2015 Target Market Cap Rs 5,000 crore and Industry – Pharma R&D First day – 32% subscribed Advice: Buy for 2-3 years The Syngene IPO is a first time offer from the high potential sector of pharma R&D Outsourcing. The Income, EBITDA…